[{"id":"64a63344-9152-4839-863a-b7541641b72f","acronym":"","url":"https://clinicaltrials.gov/study/NCT03554434","created_at":"2021-01-18T17:29:46.739Z","updated_at":"2024-07-02T16:36:49.371Z","phase":"","brief_title":"An Expanded Access Program for AM0010 (Pegilodecakin)","source_id_and_acronym":"NCT03554434","lead_sponsor":"Eli Lilly and Company","biomarkers":" IL10","pipe":"","alterations":" ","tags":["IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e pegilodecakin (LY3500518)"],"overall_status":"No Longer Available","enrollment":"","initiation":"","start_date":"","primary_txt":"","primary_completion_date":"","study_txt":"","study_completion_date":"","last_update_posted":"2020-03-02"}]